EVALUATION OF THE MAIN DATA OF INFLAMMATORY RESPONSE TO THE BASE THERAPY OF THE JUVENILE IDIOPATHIC ARTHRITIS
Abstract
The activity of the juvenile idiopathic arthritis evaluates the speed of the process progression, intense of its clinical manifestation, effect of the carried treatment.
The aim of our study was to estimate changes of the inflammatory response signs as well as content of NF-kB due to basic therapy of the JIA.
Materials and methods. At our study, we had checked 68 children with JIA, who passed their treatment at Vinnytsya regional children’s hospital within the period from 2011 to 2014 years.
Results. At the patients we studied currency of the JIA was characterized with articular variant of the disease, mainly in monoarthritis type. Laboratory activity of the inflammatory response characterized with increased content of the C-reactive protein (71.2±3.7 %), inflammatory cytokines – ІL-1β (54.8±4.1 %) and ІL-6 (56.2±2.4 %), as well high quantity of the nuclear factor-kB (70.5±3.1 %). Currency of the JIA in children characterized with high increasing of the inflammatory response signs especially C-reactive protein (6.55(4.2;9.8)), ІL-1β (7.3(3.5;11.9)), ІL-6 (6.8(4.5;10.6)) and NF-kB (6.76 (4.8; 9.1)), that are in correlative connections with clinical signs (number of the injured and swelled joints, evaluation of the general condition of the child according to doctors and own response) of the disease activity (rxy = +0.34 up to 0.62, p< 0.01).
Conclusion. During the managing of the basic therapy in children with JIA we estimated decreasing of the IL-1β content in patients at the background of methotrexate administration (38.7±3.7 %), at the second group with use of sulfasalazine (28.5±3.5 %) and the third with leflunomide prescription (29.1±5.1 %), but significant decreasing of the ІL-6 content, that is one of the main inflammatory mediators and as well NF-kB was found just in group of the patients with methotrexate administration (on 36.3±3.8 % and 32.4±2.4 % for NF-kB).
Downloads
References
Ghosh, S., May, M. J., Kopp, E. B. (1998). NF-κB and Rel proteins: Evolutionarily Conserved Mediators of Immune Responses. Annual Review of Immunology, 16 (1), 225–260. doi: http://doi.org/10.1146/annurev.immunol.16.1.225
Hahn, Y.-S., Kim, J.-G. (2010). Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis. Korean Journal of Pediatrics, 53 (11), 921–930. doi: http://doi.org/10.3345/kjp.2010.53.11.921
Van den Ham, H.-J., de Jager, W., Bijlsma, J. W. J., Prakken, B. J., de Boer, R. J. (2009). Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis. Rheumatology, 48 (8), 899–905. doi: http://doi.org/10.1093/rheumatology/kep125
Kemper, A. R., Van Mater, H. A., Coeytaux, R. R., Williams, J. W., Sanders, G. D. (2012). Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis. BMC Pediatrics, 12 (1), 1471–1479. doi: http://doi.org/10.1186/1471-2431-12-29
Isennock, M., Grosel, J. M. (2011). Juvenile idiopathic arthritis: Can you recognize this complex diagnosis? Journal of the American Academy of Physician Assistants, 24 (1), 22–27. doi: http://doi.org/10.1097/01720610-201101000-00005
Martini, A. (2012). It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Annals of the Rheumatic Diseases, 71 (9), 1437–1439. doi: http://doi.org/10.1136/annrheumdis-2012-201388
Dueckers, G., Guellac, N., Arbogast, M., Dannecker, G., Foeldvari, I., Frosch, M. et. al. (2011). German evidence and consensus based guidelines 2010 for the treatment of juvenile idiopathic arthritis (JIA). Pediatric Rheumatology, 9, 181. doi: http://doi.org/10.1186/1546-0096-9-s1-p181
Lin, Y.-T., Wang, C.-T., Gershwin, M. E., Chiang, B.-L. (2011). The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmunity Reviews, 10 (8), 482–489. doi: http://doi.org/10.1016/j.autrev.2011.02.001
Omar, A., Abo-Elyoun, I., Hussein, H., Nabih, M., Atwa, H., Gad, S., Emad, Y. (2013). Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): Correlations with disease activity and severity of joint damage (a multicenter trial). Joint Bone Spine, 80 (1), 38–43. doi: http://doi.org/10.1016/j.jbspin.2012.03.008
Rosendahl, K. (2011). Juvenile idiopathic arthritis–recent advances. Pediatric Radiology, 41, 110–112. doi: http://doi.org/10.1007/s00247-011-2054-y
Copyright (c) 2018 Yulia Vyzhga
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
